Novel Statistically-Derived Composite Measures for Assessing the Efficacy of Disease-Modifying Therapies in Prodromal Alzheimer's Disease Trials: An AIBL Study.
Burnham SC, Raghavan N, Wilson W, Baker D, Ropacki MT, Novak G, Ames D, Ellis K, Martins RN, Maruff P, Masters CL, Romano G, Rowe CC, Savage G, Macaulay SL, Narayan VA; Alzheimer’s Disease Neuroimaging Initiative; AIBL Research Group.
Burnham SC, et al. Among authors: narayan va.
J Alzheimers Dis. 2015;46(4):1079-89. doi: 10.3233/JAD-143015.
J Alzheimers Dis. 2015.
PMID: 26402634